DDR2 and breast carcinoma: In summary, we provide evidence and mechanism for the action of the collagen binding receptor DDR2, primarily in cancer associated fibroblasts, as a critical pathway controlling the tumor permissive ECM that forms in aggressive breast cancers and that facilitates or supports tumor cell invasion, migration and metastasis.